283 related articles for article (PubMed ID: 36874133)
1. Serum cytokine levels and other associated factors as possible immunotherapeutic targets and prognostic indicators for lung cancer.
Zhao Y; Jia S; Zhang K; Zhang L
Front Oncol; 2023; 13():1064616. PubMed ID: 36874133
[TBL] [Abstract][Full Text] [Related]
2. Potential predictive value of change in inflammatory cytokines levels subsequent to initiation of immune checkpoint inhibitor in patients with advanced non-small cell lung cancer.
Lim JU; Yoon HK
Cytokine; 2021 Feb; 138():155363. PubMed ID: 33264749
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment serum levels of cytokines and cytokine receptors in patients with non-small cell lung cancer, and correlations with clinicopathological features and prognosis. M-CSF - an independent prognostic factor.
Kaminska J; Kowalska M; Kotowicz B; Fuksiewicz M; Glogowski M; Wojcik E; Chechlinska M; Steffen J
Oncology; 2006; 70(2):115-25. PubMed ID: 16645324
[TBL] [Abstract][Full Text] [Related]
4. Cytokine profile determined by data-mining analysis set into clusters of non-small-cell lung cancer patients according to prognosis.
Barrera L; Montes-Servín E; Barrera A; Ramírez-Tirado LA; Salinas-Parra F; Bañales-Méndez JL; Sandoval-Ríos M; Arrieta Ó
Ann Oncol; 2015 Feb; 26(2):428-35. PubMed ID: 25467015
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of serum soluble interleukin-23 receptor and related T-helper 17 cell cytokines in non-small cell lung carcinoma.
Liu D; Xing S; Wang W; Huang X; Lin H; Chen Y; Lan K; Chen L; Luo F; Qin S; Liang R; Bai C; Xu J; Liu W
Cancer Sci; 2020 Apr; 111(4):1093-1102. PubMed ID: 32020720
[TBL] [Abstract][Full Text] [Related]
6. Serum cytokines predict efficacy and toxicity, but are not useful for disease monitoring in lung cancer treated with PD-(L)1 inhibitors.
Schindler H; Lusky F; Daniello L; Elshiaty M; Gaissmaier L; Benesova K; Souto-Carneiro M; Angeles AK; Janke F; Eichhorn F; Kazdal D; Schneider M; Liersch S; Klemm S; Schnitzler P; Stenzinger A; Sültmann H; Thomas M; Christopoulos P
Front Oncol; 2022; 12():1010660. PubMed ID: 36387148
[TBL] [Abstract][Full Text] [Related]
7. A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications.
Lauta VM
Cancer; 2003 May; 97(10):2440-52. PubMed ID: 12733143
[TBL] [Abstract][Full Text] [Related]
8. Serum cytokine levels for predicting immune-related adverse events and the clinical response in lung cancer treated with immunotherapy.
Zhao N; Yi Y; Cao W; Fu X; Mei N; Li C
Front Oncol; 2022; 12():923531. PubMed ID: 36091125
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cell immunotherapy combined with cytokine-induced killer cells promotes skewing toward Th2 cytokine profile in patients with metastatic non-small cell lung cancer.
Zhao P; Bu X; Wei X; Sun W; Xie X; Li C; Guo Q; Zhu D; Wei X; Gao D
Int Immunopharmacol; 2015 Apr; 25(2):450-6. PubMed ID: 25698555
[TBL] [Abstract][Full Text] [Related]
10. Construction of a B cell-related gene pairs signature for predicting prognosis and immunotherapeutic response in non-small cell lung cancer.
Li X; Wang R; Wang S; Wang L; Yu J
Front Immunol; 2022; 13():989968. PubMed ID: 36389757
[TBL] [Abstract][Full Text] [Related]
11. Cooperation of liver cells in health and disease.
Kmieć Z
Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
[TBL] [Abstract][Full Text] [Related]
12. Identification of serum inflammatory markers as classifiers of lung cancer mortality for stage I adenocarcinoma.
Meaney CL; Zingone A; Brown D; Yu Y; Cao L; Ryan BM
Oncotarget; 2017 Jun; 8(25):40946-40957. PubMed ID: 28402963
[TBL] [Abstract][Full Text] [Related]
13. Systematic analysis of IL-6 as a predictive biomarker and desensitizer of immunotherapy responses in patients with non-small cell lung cancer.
Liu C; Yang L; Xu H; Zheng S; Wang Z; Wang S; Yang Y; Zhang S; Feng X; Sun N; Wang Y; He J
BMC Med; 2022 May; 20(1):187. PubMed ID: 35550592
[TBL] [Abstract][Full Text] [Related]
14. Novel cytokines: IL-27, IL-29, IL-31 and IL-33. Can they be useful in clinical practice at the time diagnosis of lung cancer?
Naumnik W; Naumnik B; Niewiarowska K; Ossolinska M; Chyczewska E
Exp Oncol; 2012 Dec; 34(4):348-53. PubMed ID: 23302994
[TBL] [Abstract][Full Text] [Related]
15. Clinical value of serum and exhaled breath condensate inflammatory factor IL-11 levels in non-small cell lung cancer: Clinical value of IL-11 in non-small cell lung cancer.
Wu J; Chen J; Lv X; Yang Q; Yao S; Zhang D; Chen J
Int J Biol Markers; 2021 Jun; 36(2):64-76. PubMed ID: 34142593
[TBL] [Abstract][Full Text] [Related]
16. Potential predictors of immunotherapy in small cell lung cancer.
Skopelidou V; Strakoš J; Škarda J; Raška M; Kafková-Rašková L
Pathol Oncol Res; 2023; 29():1611086. PubMed ID: 37206058
[TBL] [Abstract][Full Text] [Related]
17. Serum cytokine analysis in a cohort of advanced non-small cell lung cancer treated with PD-1 inhibitors reveals predictive markers of CXCL12.
Xu Y; Ding L; Li H; Peng Z; Ding K; Huang Z; Zhou Z; Xie M; Yan J; Feng S; Fan Y
Front Immunol; 2023; 14():1194123. PubMed ID: 37359565
[TBL] [Abstract][Full Text] [Related]
18. The Significance of the PD-L1 Expression in Non-Small-Cell Lung Cancer: Trenchant Double Swords as Predictive and Prognostic Markers.
Takada K; Toyokawa G; Shoji F; Okamoto T; Maehara Y
Clin Lung Cancer; 2018 Mar; 19(2):120-129. PubMed ID: 29153898
[TBL] [Abstract][Full Text] [Related]
19. Diospyros malabarica fruit preparation mediates immunotherapeutic modulation and epigenetic regulation to evoke protection against non-small cell lung cancer (NSCLC).
Bhootra S; Jill N; Rajak R; Shanmugam G; Rakshit S; Kannanthodi S; Thakkar V; George M; Sarkar K
J Ethnopharmacol; 2023 Oct; 314():116525. PubMed ID: 37149067
[TBL] [Abstract][Full Text] [Related]
20. Alterations of routine blood tests in adult patients with soft tissue sarcomas: relationships to cytokine serum levels and prognostic significance.
Ruka W; Rutkowski P; Kaminska J; Rysinska A; Steffen J
Ann Oncol; 2001 Oct; 12(10):1423-32. PubMed ID: 11762815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
